Illness and Microbial Experiences of Nursery Children at Junior Village1

Abstract

Engler, J. I.; Parrott, R. H.; and Huebner, R. J. Pharyngoconjunctival Fever-Epidemiological Studies of a Recently Recognized Disease Entity. J.A.M.A. 157:1083-1092 (Mar. 26), 1955. 7. Jawetz, E.; Thygeson, P.; Hanna, L.; Nicholas, A.; and Kimura, S. J. The Etiology of Epidemic Kerato-conjunctivitis. Am. J. Ophth. 43:79-83 (Apr.), 1957. 8. Bell, J. A.; Huebner, R. J.; Rosen, L.; Rowe, W. P.; Cole, R. M.; Mastrota, F. M.; Floyd, T. M.; Chanock, R. M.; and Shvedoff, R.

Ocorrência de adenovirus em crianças com gastrenterite aguda grave na Cidade de Belém, Pará, Brasil

“…Todas las muestras de adenovirus no entérico (AdNE) se encaminaron para la vía clásica de identificación viral, o 15 sea, la inoculación en células HEp-2 . Se realizó la inoculación de 0.2 mL de la muestra de suspensión fecal en la proporción de 1:8, con AdNEs, en tubos de poliestireno con células HEp-2 en monolayer, mantenidas con 1 mL (en cada tubo) de Medio Mínimo de Mantenimiento, el que contenía solución de sales balanceadas (BSS), bicarbonato de sodio, sales de "Hanks", L-glutamina, aminoácidos no esenciales y esenciales, vitaminas, coenzimas, hormonas, ácidos nucleicos y derivados y 5% de suero bovino fetal.…”

Respiratory viral infection in childhood. A survey in general practice, Roehampton 1967–1972

“…Report, 1965;Poole & Tobin, 1973), and in the U.S.A. by Glezen et al (1971) and Maletsky et al (1971). Some surveys have also been undertaken in nurseries and schools (Bell et al 1961;Pereira, Andrews & Gardner, 1967;Beem 1969;and Loda, Glezen & Clyde, 1972). Much of this work has been reviewed by Channock & Parrott (1965), by Miller (1968) and by Gardner (1968).…”

Tumors induced in hamsters by a strain of adenovirus type 3: sharing of tumor antigens and "neoantigens" with those produced by adenovirus type 7 tumors.

“…Surveys for serum antibodies to type 3 carried out in various parts of the United States, Western Europe, Russia, Japan, Australia, and Formosa indicated that 40-50 per cent of children and 50-70 per cent or more of adults had neutralizing antibodies to type 3. [33][34][35][36][37][38][39][40][41][42][43][44] In the Washington, D. C., area where contemporary serologic surveys confirm a high prevalence for neutralizing antibodies to type 3,1 45 we have evidence that this high prevalence may be the result of relatively recent events. A survey of sera taken between 1950 and 1953 from the same population showed that only 20 per cent of the children and adults (to age 35) had neutralizing antibodies to type 3.…”